The Story of Veramed – love and statistics

Interview with Emma and Matt Jones

Were there times when you thought about creating something bigger than what you had?
Are you equipped and confident enough to implement strategies and plans for future service enhancement?

If your answer is yes, I am sure that you’ll be very interested to hear the story of Matthew and Emma as they will share today their experience on how they started their own company, Veramed, in 2012 after leaving their established careers working in the industry for large pharma and CROs.

We also talk about the following points:

• What is the founding story of Veramed?
• Why did you start it in early 2012 after being a freelancer for some time?
• Leaving a nice and “secure” job at Lilly, how did that feel like and why did you leave?
• How does the business model for Veramed look like?
• How did you grow your company to get more business, recruiting new people while retaining the right people and also securing the right quality/culture?
• How did you balance family vs work being the owners of the company?

Matthew Jones

Co-Founder and Chief Executive Officer

Matthew’s responsibilities include the provision of strategic direction and operational leadership to the company. He also provides oversight and management for the delivery of key projects.

Matthew began his pharmaceutical career in SAS programming with Oxford Pharmaceutical Sciences (now Quanticate), where he honed his technical skills through various positions of ascending seniority. He subsequently worked in a variety of freelance and permanent programming positions across the industry for both CRO and large Pharma, and developed a deep working knowledge of several different outsourcing models.

Matthew holds a BSc in Economics from the University of Nottingham (1999) and an executive MBA from Cranfield University (2006).

Emma Jones

Co-Founder and Executive Vice President, Statistics

Emma is responsible for enabling the Veramed Biostatistics team to achieve the highest levels of quality from consultancy to reporting. Emma continues to provide statistical consultancy to clients to maintain her statistical acumen.

Emma has a wealth of experience in vendor oversight, statistical consultancy and of clinical statistical analysis gained from a variety of leading global pharmaceutical companies. She has knowledge in both technical and non-technical aspects of study design and statistical analysis across clinical studies from Phase I-III and multiple therapeutic areas, including oncology, respiratory and immunology.

Emma holds a PhD in Statistics and is an active member of Statisticians in Pharmaceutical Industry (PSI). Emma was the Conference Chair for the 2015 and 2016 annual conference in London and Berlin, respectively.

Listen to this episode to learn a lot and share this with your friends and colleagues!